84 related articles for article (PubMed ID: 12569607)
1. Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas.
Tortosa A; Viñolas N; Villà S; Verger E; Gil JM; Brell M; Caral L; Pujol T; Acebes JJ; Ribalta T; Ferrer I; Graus F
Cancer; 2003 Feb; 97(4):1063-71. PubMed ID: 12569607
[TBL] [Abstract][Full Text] [Related]
2. Can quantifying the extent of 'high grade' features help explain prognostic variability in anaplastic astrocytoma?
Goacher E; Mathew R; Fayaye O; Chakrabarty A; Feltbower R; Loughrey C; Roberts P; Chumas P
Br J Neurosurg; 2024 Apr; 38(2):314-321. PubMed ID: 33377401
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognostic factors of solitary and multiple adult gliomas: a retrospective study based on propensity score matching.
Huang R; Wu H; Lu X; Sun X
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10481-10498. PubMed ID: 37975372
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors analysis of diffuse midline glioma.
Jiang J; Li WB; Xiao SW
J Neurooncol; 2024 Apr; 167(2):285-292. PubMed ID: 38381257
[TBL] [Abstract][Full Text] [Related]
5. Classification of unilateral thalamic gliomas predicts tumor resection and patient's survival: a single center retrospective study.
Que T; Li Z; Zheng H; Tan JE; Yuan X; Yi G; Fang L; Nie J; Yin Y; Xu H; Zheng X; Liu J; Zhang XA; Qi S; Huang G
J Neurosurg Sci; 2022 Apr; ():. PubMed ID: 35416455
[TBL] [Abstract][Full Text] [Related]
6. Postoperative prognostic nomogram for adult grade II/III astrocytoma in the Chinese Han population.
Wang L; Zhang J; Wang J; Xue H; Deng L; Che F; Heng X; Zheng X; Lu Z; Yang L; Tan Q; Xu Y; Zhang Y; Ji X; Li G; Yang F; Xue F
Health Inf Sci Syst; 2023 Dec; 11(1):23. PubMed ID: 37151917
[TBL] [Abstract][Full Text] [Related]
7. Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas.
Hong JB; Roh TH; Kang SG; Kim SH; Moon JH; Kim EH; Ahn SS; Choi HJ; Cho J; Suh CO; Chang JH
Cancer Res Treat; 2020 Oct; 52(4):1041-1049. PubMed ID: 32324987
[TBL] [Abstract][Full Text] [Related]
8. Individualized discrimination of tumor recurrence from radiation necrosis in glioma patients using an integrated radiomics-based model.
Wang K; Qiao Z; Zhao X; Li X; Wang X; Wu T; Chen Z; Fan D; Chen Q; Ai L
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1400-1411. PubMed ID: 31773234
[TBL] [Abstract][Full Text] [Related]
9. Impact of fluorescence-guided surgery on the improvement of clinical outcomes in glioblastoma patients.
Kim SK; Choi SH; Kim YH; Park CK
Neurooncol Pract; 2014 Sep; 1(3):81-85. PubMed ID: 31386036
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population-based study.
Fang JH; Lin DD; Deng XY; Li DD; Sheng HS; Lin J; Zhang N; Yin B
Cancer Med; 2019 Jun; 8(6):3286-3295. PubMed ID: 31016895
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma.
Bagley SJ; Schwab RD; Nelson E; Viaene AN; Binder ZA; Lustig RA; O'Rourke DM; Brem S; Desai AS; Nasrallah MP
J Neurooncol; 2019 Jan; 141(2):421-429. PubMed ID: 30446903
[TBL] [Abstract][Full Text] [Related]
12. Comparison of chemoradiotherapy with radiotherapy alone for "biopsy only" anaplastic astrocytoma.
Wu J; Zou T; Bai HX; Li X; Zhang Z; Xiao B; Nasrallah M; Karakousis G; Cao Y; Zhang PJ; Yang L
Oncotarget; 2017 Sep; 8(40):69038-69046. PubMed ID: 28978179
[TBL] [Abstract][Full Text] [Related]
13. Reclassification of Mixed Oligoastrocytic Tumors Using a Genetically Integrated Diagnostic Approach.
Kim SI; Lee Y; Won JK; Park CK; Choi SH; Park SH
J Pathol Transl Med; 2018 Jan; 52(1):28-36. PubMed ID: 28958143
[TBL] [Abstract][Full Text] [Related]
14. Correlation Between Ki-67 Index, World Health Organization Grade and Patient Survival in Glial Tumors With Astrocytic Differentiation.
Stoyanov GS; Dzhenkov DL; Kitanova M; Donev IS; Ghenev P
Cureus; 2017 Jun; 9(6):e1396. PubMed ID: 28845375
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors for survival and treatment outcome of high-grade glioma in Prasat Neurological Institute.
Noiphithak R; Veerasarn K
Asian J Neurosurg; 2017; 12(1):28-33. PubMed ID: 28413528
[TBL] [Abstract][Full Text] [Related]
16. Radiological imaging features of glioblastoma with oligodendroglioma component: a comparison with conventional glioblastoma.
Kanoto M; Kirii K; Toyoguchi Y; Nishihara M; Sakurai K; Murayama K; Noguchi T; Matsuda K; Sakurada K; Sonoda Y; Hosoya T
Acta Radiol Open; 2016 Nov; 5(11):2058460116675191. PubMed ID: 27900202
[TBL] [Abstract][Full Text] [Related]
17. Maximizing safe resection of low- and high-grade glioma.
Hervey-Jumper SL; Berger MS
J Neurooncol; 2016 Nov; 130(2):269-282. PubMed ID: 27174197
[TBL] [Abstract][Full Text] [Related]
18. Identifying the association between contrast enhancement pattern, surgical resection, and prognosis in anaplastic glioma patients.
Wang Y; Wang K; Wang J; Li S; Ma J; Dai J; Jiang T
Neuroradiology; 2016 Apr; 58(4):367-74. PubMed ID: 26795126
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.
Wang YY; Wang K; Li SW; Wang JF; Ma J; Jiang T; Dai JP
AJNR Am J Neuroradiol; 2015 Nov; 36(11):2023-9. PubMed ID: 26316565
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH
Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
